发明名称 |
FLUORINATED TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS |
摘要 |
<p>The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.</p> |
申请公布号 |
EP2224942(A4) |
申请公布日期 |
2012.01.25 |
申请号 |
EP20080859987 |
申请日期 |
2008.12.04 |
申请人 |
ENANTA PHARMACEUTICALS, INC. |
发明人 |
GAI, YONGHUA;OR, YAT, SUN;WANG, ZHE |
分类号 |
A61K38/06 |
主分类号 |
A61K38/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|